Search results for "MDM"

showing 10 items of 93 documents

Acute behavioural and neurotoxic effects of MDMA plus cocaine in adolescent mice.

2008

The poly-drug pattern is the most common among those observed in MDMA users, with cocaine being a frequently associated drug. This study evaluates the acute effects of MDMA (5, 10 and 20 mg/kg), alone or in combination with cocaine (25 mg/kg), on motor activity, anxiety (elevated plus maze and social interaction test), memory and brain monoamines in adolescent mice, Both drugs, administered alone or concurrently, produced hyperactivity and a decrease in social contacts. However, an anxiolytic effect, studied by means of the elevated plus maze and expressed as an increase in the time spent on the open arms, was observed only in those animals treated with cocaine and MDMA. The passive avoidan…

MaleSerotoninElevated plus mazeMDMAmedicine.drug_classDopamineN-Methyl-34-methylenedioxyamphetamineStriatumPharmacologyAnxietyMotor ActivityToxicologyAnxiolyticHippocampusCellular and Molecular NeuroscienceMiceSerotonin AgentsDevelopmental NeuroscienceCocaineDopaminemental disordersmedicineAvoidance LearningAnimalsBiogenic MonoaminesInterpersonal RelationsBrain ChemistryCerebral CortexBehavior AnimalMDMACortex (botany)NeostriatumSocial behaviourAnxietyNeurotoxicity SyndromesSerotoninmedicine.symptomElevated plus mazePsychologypsychological phenomena and processesmedicine.drugNeurotoxicology and teratology
researchProduct

Behavioural and neurotoxic long-lasting effects of MDMA plus cocaine in adolescent mice

2008

The poly-drug pattern is the most common among MDMA users, with cocaine being a frequently associated drug. The aim of the present work was to evaluate the behavioural and neurotoxic long-term effects of exposure during adolescence to MDMA alone or plus cocaine. Mice of 28 to 30 days of age received a treatment of two daily injections of an identical dose of MDMA (5, 10 or 20 mg/kg), alone or plus cocaine (25 mg/kg), for 3 days (6 administrations). Three weeks after receiving MDMA, an increase in the time dedicated by the animals to social contacts with their conspecifics was observed, whilst their behaviour in the elevated plus maze showed no differences from that of non-treated mice. Afte…

MaleSerotoninElevated plus mazemedicine.drug_classDopamineN-Methyl-34-methylenedioxyamphetamineMotor ActivityPharmacologyAnxiolyticBody TemperatureMicechemistry.chemical_compoundCocaineDopaminemental disordersmedicineAnimalsMaze LearningSocial BehaviorNeurotransmitterPharmacologyBehavior AnimalLocal anestheticDopaminergicBrainMDMACorpus StriatumchemistrySerotoninPsychologypsychological phenomena and processesmedicine.drugEuropean Journal of Pharmacology
researchProduct

Neurochemical Substrates of MDMA Reward: Effects of the Inhibition of Serotonin Reuptake on the Acquisition and Reinstatement of MDMA-induced CPP

2013

Different neurotransmitter brain systems have been implicated in the rewarding effects of 3,4-methylenedioxymetamphetamine (MDMA), including dopamine or serotonin. Serotonin selective reuptake inhibitors (SSRI) are a commonly prescribed therapy for psychiatric disorders, and the SSRI fluoxetine is recommended for MDMA users due to its neuroprotective effect against MDMAinduced neurotoxicity. In the present work, we employed the conditioned place preference (CPP) paradigm to study how the inhibition of serotonin reuptake with fluoxetine affected the rewarding and reinstating effects of MDMA in adolescent male mice. Firstly, we evaluated the motivational effects of fluoxetine (1 and 10 mg/kg)…

MaleSerotoninN-Methyl-34-methylenedioxyamphetaminePharmacologyMicechemistry.chemical_compoundNeurochemicalRewardDopamineFluoxetineConditioning Psychologicalmental disordersDrug DiscoveryAnimalsMedicineNeurotransmitterPharmacologyFluoxetineDose-Response Relationship Drugbusiness.industryMDMAConditioned place preferencechemistryHallucinogensSerotoninbusinessReuptake inhibitorSelective Serotonin Reuptake Inhibitorspsychological phenomena and processesmedicine.drugCurrent Pharmaceutical Design
researchProduct

Adolescent pre-exposure to ethanol or MDMA prolongs the conditioned rewarding effects of MDMA

2011

Adolescents often take ethanol (EtOH) in combination with MDMA (3,4-methylenedioxymethylamphetamine). In the present work we studied the effect of repeated intermittent adolescent pre-exposure to both drugs on the behavioral and neurochemical effects of MDMA in mice. Sixteen days after pre-treatment, the rewarding and reinstating effects of MDMA in the conditioned place preference (CPP) paradigm were evaluated, along with the levels of biogenic amines, basal motor activity and corticosterone response to different challenges. Pre-exposure to EtOH, MDMA or EtOH+MDMA did not affect the CPP induced by 10mg/kg of MDMA. However, adolescent exposure to EtOH or MDMA increased the duration of the co…

MaleSerotoninmedicine.medical_specialtyDopamineN-Methyl-34-methylenedioxyamphetaminePoison controlExperimental and Cognitive PsychologyStriatumMotor ActivityChoice BehaviorHippocampusDrug Administration ScheduleExtinction PsychologicalMiceBehavioral Neurosciencechemistry.chemical_compoundNeurochemicalRewardCorticosteroneInternal medicineConditioning Psychologicalmental disordersAnimals Outbred StrainsmedicineAnimalsDrug InteractionsCerebral CortexEthanolIllicit DrugsMDMAExtinction (psychology)Hydroxyindoleacetic AcidCorpus StriatumConditioned place preferenceMonoamine neurotransmitterEndocrinologychemistryAnesthesia34-Dihydroxyphenylacetic AcidCorticosteronePsychologypsychological phenomena and processesmedicine.drugPhysiology & Behavior
researchProduct

Effect of intermittent exposure to ethanol and MDMA during adolescence on learning and memory in adult mice

2012

Abstract Background Heavy binge drinking is increasingly frequent among adolescents, and consumption of 3,4-methylenedioxymethamphetamine (MDMA) is often combined with ethanol (EtOH). The long-lasting effects of intermittent exposure to EtOH and MDMA during adolescence on learning and memory were evaluated in adult mice using the Hebb-Williams maze. Methods Adolescent OF1 mice were exposed to EtOH (1.25 g/kg) on two consecutive days at 48-h intervals over a 14-day period (from PD 29 to 42). MDMA (10 or 20 mg/kg) was injected twice daily at 4-h intervals over two consecutive days, and this schedule was repeated six days later (PD 33, 34, 41 and 42), resulting in a total of eight injections. …

MaleSerotoninmedicine.medical_specialtyMDMA34-Dihydroxyphenylacetic acidDopamineN-Methyl-34-methylenedioxyamphetamineCognitive NeuroscienceBinge drinkingStriatumHippocampuslcsh:RC346-429MiceBehavioral Neurosciencechemistry.chemical_compoundSerotonin AgentsMemoryDopamineSerotonin AgentsInternal medicinemental disordersmedicineAnimalsLearningHippocampus (mythology)Maze Learninglcsh:Neurology. Diseases of the nervous systemBiological PsychiatryBehavior AnimalEthanolResearchMDMAGeneral MedicineHydroxyindoleacetic AcidCorpus StriatumEndocrinologychemistryAnesthesia34-Dihydroxyphenylacetic AcidHebb Williams mazeSerotoninPsychologypsychological phenomena and processesmedicine.drugBehavioral and Brain Functions
researchProduct

Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations

1994

The genetics of Wilms' tumour (WT), a paediatric malignancy of the kidney, is complex. Inactivation of the tumour suppressor gene, WT1, is associated with tumour aetiology in approximately 10-15% of WTs. Chromosome 17p changes have been noted in cytogenetic studies of WTs, prompting us to screen 140 WTs for p53 mutations. When histopathology reports were available, p53 mutations were present in eight of eleven anaplastic WTs, a tumour subtype associated with poor prognosis. Amplification of MDM2, a gene whose product binds and sequesters p53, was excluded. Our results indicate that p53 alterations provide a molecular marker for anaplastic WTs.

MaleTumor suppressor geneDNA Mutational AnalysisMolecular Sequence DataGene mutationBiologyMalignancymedicine.disease_causePolymerase Chain ReactionWilms TumorProto-Oncogene ProteinsGeneticsmedicineHumansAmino Acid SequenceGeneAllelesMutationBase SequencefungiNuclear ProteinsCell DifferentiationProto-Oncogene Proteins c-mdm2Wilms' tumorGenes p53Prognosismedicine.diseaseKidney NeoplasmsNeoplasm ProteinsGene Expression Regulation Neoplasticbody regionsGenetic markerbiology.proteinCancer researchMdm2FemaleTumor Suppressor Protein p53Nature Genetics
researchProduct

Role of NMDA and AMPA glutamatergic receptors in the effects of social defeat on the rewarding properties of MDMA in mice

2019

Exposure to social stress alters the response to drugs of abuse of experimental animals. Changes in the glutamatergic system seem to play a role in the effects of social defeat stress on the rewarding properties of cocaine and amphetamine. The aim of the present study was to evaluate the involvement of N-methyl-D-aspartate (NMDA) and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) glutamate receptors in the effects of social defeat on the conditioned place preference induced by 3,4-methylenedioxymethamphetamine (MDMA). Our hypothesis was that changes in these receptors could mediate the effects of social defeat on MDMA reward. Young adult male mice were exposed to an episode…

Maledrug addictionglutamate receptorN-Methyl-34-methylenedioxyamphetamineAMPA receptorPharmacologyReceptors N-Methyl-D-AspartateSocial defeatMice03 medical and health scienceschemistry.chemical_compoundstress0302 clinical medicineRewardConditioning PsychologicalmedicineAnimalsReceptors AMPASocial BehaviorAmphetamine030304 developmental biologySocial stress0303 health sciencesAdrenergic Uptake Inhibitorsbusiness.industryGeneral NeuroscienceMemantineMDMAconditioned place preferenceConditioned place preferencechemistrynervous systemCNQXbusinessExcitatory Amino Acid AntagonistsStress Psychological030217 neurology & neurosurgerymedicine.drug
researchProduct

The novelty-seeking phenotype modulates the long-lasting effects of adolescent MDMA exposure.

2015

Exposure to drugs such as ethanol or cocaine during adolescence induces alterations in the central nervous system that are modulated by the novelty-seeking trait. Our aim was to evaluate the influence of this trait on the long-term effects of MDMA administration during adolescence on spontaneous behavior and conditioned rewarding effects in adulthood. Adolescent mice were classified as high or low novelty seekers (HNS or LNS) according to the hole-board test and received either MDMA (0, 10 or 20mg/kg PND 33-42) or saline. Three weeks later, having entered adulthood (PND>68), one set of mice performed the elevated plus maze and social interaction tests, while another set performed the condit…

Malemedicine.medical_specialtyElevated plus mazemedicine.drug_classN-Methyl-34-methylenedioxyamphetamineCentral nervous systemPoison controlExperimental and Cognitive PsychologyStriatumMotor ActivityAnxiolyticBehavioral NeuroscienceMiceInternal medicinemental disordersmedicineAnimalsSocial BehaviorAdrenergic Uptake InhibitorsBehavior AnimalNovelty seekingAssociation LearningMDMAEndocrinologymedicine.anatomical_structurePhenotypeAnesthesiaExploratory BehaviorConditioning OperantSerotoninPsychologypsychological phenomena and processesmedicine.drugPhysiologybehavior
researchProduct

Long-term effects of repeated social stress on the conditioned place preference induced by MDMA in mice.

2015

Previous studies have demonstrated that social defeat stress increases the rewarding effects of psychostimulant drugs such as cocaine and amphetamine. In the present study we evaluated the long-term effects of repeated social defeat (RSD) on the rewarding effects of ±3,4-methylenedioxymethamphetamine (MDMA) hydrochloride in the conditioned place preference (CPP) paradigm. Adolescent and young adult mice were exposed to four episodes of social defeat (on PND 29-40 and PND 47-56, respectively) and were conditioned three weeks later with 1.25 or 10mg/kg i.p. of MDMA (experiment 1). The long-term effects of RSD on anxiety, social behavior and cognitive processes were also evaluated in adult mic…

Malemedicine.medical_specialtyN-Methyl-34-methylenedioxyamphetamineDevelopmental psychologyExtinction PsychologicalSocial defeatMiceAdrenal Cortex HormonesInternal medicinemental disordersmedicineAvoidance LearningAnimalsInterpersonal RelationsYoung adultAmphetamineMaze LearningBiological PsychiatryPharmacologySocial stressAnalysis of VarianceDose-Response Relationship DrugAge FactorsMDMAConditioned place preferenceSocial relationEndocrinologyHallucinogensAnxietyConditioning Operantmedicine.symptomPsychologyReinforcement Psychologypsychological phenomena and processesStress Psychologicalmedicine.drugProgress in neuro-psychopharmacologybiological psychiatry
researchProduct

Framework and Research Agenda for Master Data Management in Distributed Environments

2011

Master data is the foundation for relating business transactions with business entities such as customers, products, locations etc. These entities are also referred to as domains in master data literature. The integrity, availability and timeliness of master data in single-, and growingly in multi-domain combinations is crucial in eBusiness transactions over the Internet, or in the cloud for multiple stakeholders. Distributed environments set additional challenges for the management of master data. In this idea paper, we first describe master data, management processes, responsibilities and other contemporary master data management practices aiming to ensure master data quality in different…

Master Data managementtiedonhallintaMDMData Governancekokonaisarkkitehtuurimaster datamaster data organization
researchProduct